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The steps involved in the maturation of normal bone marrow-derived (B) 
lymphocytes into immunoglobulin (Ig)-secreting plasma cells after antigenic 
or mitogenic stimulation have been described according to cellular morphology 
in morphology in electron micrographs (1, 2), immunofluorescent analysis of 
surface-bound and intracytoplasmic Ig (3), and biochemical studies of IgM 
synthesis, surface representation, and secretion (4-6). In the present studies 
the state of maturation of cells obtained from five routine IgM-producing 
lymphocytomas has been characterized by a variety of morphological nd bio- 
chemical criteria. The degree of maturity of each of these cell populations has 
been assessed by comparison to normal mitogen-stimulated B lymphocytes. 
Materials and Methods 
Turnors.--Mouse tumors transplantable in BALD/c-mice were obtained from Doctors 
K. R. Mclntire and M. Potter, National Cancer Institute, NIH, Bethesda, Md. (McPc 1748, 
TEPC 183, and McPc 774) or from Doctors Melvin Cohn and Judith Hirst at the Salk Insti- 
tute, La Julia, Calif. (Y 5781, W 3469). Tumors were grown subcutaneously. 
Morphology.--Animals were sacrificed by exsanguination under light ether anaesthesia. 
Sera were collected an stored for serologic studies. Organs were examined in situ or removed 
aseptically for further studies. Subcutaneous tumors were p epared for morphologic studies 
by four methods. Imprints were made from freshly cut tumor surfaces and stained with 
Wright's and Giemsa stains. Blocks 30-50 mm on a side were fix d in 109~ formalin, embedded, 
cut, and stained with hematoxylin and eosin. Cell suspensions were spun in a cytocentrifuge 
and stained with Wright's and Giemsa stains. Additional fresh tumor was cut into 1 2 mm 
cubes, placed in 1.5% glutaraldehyde in 0.1 ml sodium cacodylate, coded, and prepared for 
electron microscopy (7). 
* During these studies Dr. Douglas was supported by U.S. Public Health Service RCDA- 
l-K0-4 HL-42575 and NIH grant AI-09338. Dr. Buxbaum was supported by NIH grant 
CA 12152 and a Research and Educational Associateship of the Veterans Administration. 
Present address: Department of Medicine, New York University College of Medicine, 
New York 10016. 
§ Present address: Department of Medicine, University of Minnesota Medical School, 
Minneapolis, Minn. 55455. 
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ANDERSSON ET  AL. 743 
Immunofluoreseence.-- 
Antisera: A specific antimouse/z-chain a tiserum was raised in rabbits by injection of 
purified IgM mouse myeloma protein MOPC 104, followed by absorption of the serum with a 
mixture of purified IgG, and IgA myeloma proteins, made insoluble by cross-linking with 
ethylchloroformate (8). The specificity of the antiserum was assessed by immunodiffusion i  
agarose gel. A further control for specificity was performed after conjugation with fluoro- 
chrome by staining of IgM and IgG plasma cells. The antiserum did not stain an IgGl-pro- 
ducing myeloma cell line, which was stained both on the membrane and in the cytoplasm by a 
specific anti-IgG1 antiserum. The IgG fraction of the antiserum, prepared by ammonium 
sulfate precipitation and DEAE chromatography, was labeled with fluorescein or rhodamine 
isothiocyanate (Baltimore Biological Labs., Baltimore, Md.) according to Cebra and Gold- 
stein (9). 
Staining o/cells: Cell suspensions were prepared from the solid tumors by teasing on 
stainless teel gauze. After allowing spontaneous sedimentation f cell clumps, the suspensions 
were washed twice in the cold in Hank's balanced salt solution -F 10% fetal calf serum. 
Double staining of cells for surface and intracytoplasmic immunoglobulins was performed 
as described by Pernis et al. (3). Briefly, the cell suspensions were incubated in the cold with 
an equal vol of rhodamine-conjugated antiserum for 30 min in an ice bath, and washed three 
times with cold medium. The pellet was then resuspended in 3% bovine serum albumin in 
phosphate-buffered saline (PBS) 1 and smeared on slides by means of a Shandon-Elliot cyto- 
centrifuge (Shandon Scientific Co., Inc., Sewickley, Pa.). The cell smears were fixed for 10 
min in 95% ethanol, rehydrated in several changes of PBS, and exposed to the fluorescein- 
conjugated antiserum for 45 min at room temperature in a moist chamber. After thorough 
washing in PBS, the slides were mounted in phosphate-buffered glycerol. 
Microscopy: The preparations were observed under a Leitz Orthoplan microscope 
equipped with an Opak-Fluor vertical Illuminator (Leitz GmbH, Wetzlar, Germany), using 
selective illumination for fluorescein or rhodamine (10). Photographs were recorded on Kodak- 
Tri Pan 23 DIN black-white film. 
Biosynthetic St~uties.--Preparation f cell suspensions, cell viability determinations, label- 
ing of cells with L-[4,5-3H]leucine (50 Ci/mmol, 66 #Ci/ml, batch 40), n-[1-3Hlmannose 
(3.3 Ci/mmol, 50/zCi/ml, batch 13), D-[1-3H]galactose (5.7 Ci/mmol, 50 ~Ci/ml, batch 13) and 
L-[l-3H]fucose (2.82 Ci/mmol, 50/zCi/ml, batch 5), all from the Radiochemical Centre, Amer- 
sham, England), separation of the labeled cells from their supernatant medium, lysis of cells 
with Nonidet P40 (NP-40, Shell Chemical Co., Ztirich, Switzerland), nonionic detergent, di- 
alysis of cell lysates and supernatant media, centrifugation of the dialyzed lysates at 22,000 
g for 2 h, determinations of total radioactivity incorporated into macromolecular, nondi- 
alyzable material, and into serologically precipitable material have been described else- 
where (4, 5). Serological precipitations were done by reacting soluble complexes of radioactive 
mouse myeloma IgM and excess rabbit (antimouse Ig) antiserum with pig (antirabbit Ig) 
globulin at equivalence point (sandwich technique). We are grateful to Dr. F. Franek, 
Czechoslovak Academy of Sciences, Prague, Czechoslovakia, for supplies of the pig serum. 
Values obtained with specific (antimouse Ig) precipitations were corrected by subtracting 
from values obtained with nonspecific (anti-E. coli/3-galactosidase) precipitations. All sero- 
logical determinations were done at least in duplicate. The IgM-specific antisera were raised 
in rabbits by repeated injections of 1 mg each of purified (11) extracellular 19S MOPC 104E 
IgM (~,/z). The specificity of these antisera has been described (6, 12). Size and polypeptide 
chain composition of the radioactive IgM was determined in intracellular lysates or extra- 
cellular fluids by sucrose gradient sedimentation followed by serological analysis of the sucrose 
gradient fractions (6, 11), or was determined in serological precipitates from the intracell- 
l Abbre'~,iations u ed in this paper: EM, electron microscopy; LPS, lipopolysaccharide; 
PBS, phosphate-buffered saline; RER, rough endoplasmic reticulum. 
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744 FIVE IgM-PRODUCING MOUSE TUMORS 
ular lysates and the extracellular fluids containing the radioactive mouse IgM by polyacryla- 
mide gel electrophoreses. Composite gels (13) of 2.5% cross-linked polyacrylamide in 0.5% 
agarose were used for the dissociated serological precipitates for size analysis of the radio- 
active IgM, while 7.5% cross-linked polyacrylamide gels (14) were used for the disso- 
ciated, reduced, and alkylated serological precipitates for analysis of the po]ypeptide chain 
composition of radioactive mouse IgM. Both gel procedures were adapted to the soluble gel 
procedure of Choules and Zimm (15). Quantitative d terminations of radioactivity in differ- 
ent neutral hexoses and hexosamines were done by column chromatography on Dowex 2 (X 8) 
(neutral hexoses [16]) (Dowex Ion Exchange Resins, Dow Chemical Co., Midland, Mich.), 
and on Amberlite CG-120 (hexosamines [17]) (Amberlite Cation & Anion Exchange Resins, 
Rohm and Haas Co., Philadelphia) with hydrolysates and serological precipitates of radio- 
active myeloma protein as described (18). Actinomycin D was obtained from Sigma Chemical 
Co., St. Louis, Mo. 
RESULTS 
Biologic Behavior of Tumors.--McPc 1748 was obtained as a splenic tumor. 
The tumor grew only in the spleen whether it was inoculated subcutaneously 
or intraperitoneally. After the fourth passage in our laboratory a small nodule 
was noted at the site of injection of the tumor cells. The nodule was excised 
and passed subcutaneously. After three additional passages the tumor grew as 
well subcutaneously as it did in the spleen. Studies of IgM synthesis with cells 
obtained from both sites in the same animal yielded virtually identical results 
with respect o the amount of IgM synthesized relative to total cell protein and 
the pattern of assembly and secretion. All animals with subcutaneous tumors 
had enlarged, grossly infiltrated spleens at the time of sacrifice. 
W 3469 and Y 5781 grew both subcutaneously and in the spleen while animals 
with the TEPC 183 and McPc 774 tumors had some splenic enlargement but 
no gross infiltration. When minced spleens from mice bearing the latter two 
tumors were injected into new animals, either intraperitoneally or subcutane- 
ously, tumors appeared in 20 50% of the animals. Hence the degree of splenic 
colonization achieved by cells from these two tumors appeared to be somewhat 
less than that of the others. Mean survival times were ascertained by the sub- 
cutaneous injection of 10 ~ viable tumor cells per animal into groups of six-ten 
animals per tumor and observing the animals daily until death (Table I). 
TABLE I 
Characterization f Five IgM-Producing Mouse Tumors 
Tumor 
Med. Immunofluoresce nce 
Group surv. time Splenic (days) homing Cytoplasmic Membrane- 
IgM bound IgM 
Electron microscopy 
Free Bound A-particles polysomes polysomes 
1748 I 30 4-4-+ 4- 4-4-+ 4-4-+ -- -- 
3469 I 21 4-4-+ 4- +4-4-+ +4-4- -- -- 
5781 II 28 4-4- 4-4-+ 4- 4-4- 4-4- 4- 
774 II <50 4- 4--t-4-4- -- 4- 4-4-4-4- 4-4-4- 
183 II 23 4- 4-4-4- -- 4- 4-4-4-4- 4-4-4-4- 
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ANDERSSON ET AL. 745 
Immunofluorescence.--All tumors gave suspensions of large cells, with the 
nucleus of considerable size. However, the average cell diameter was smaller 
in tumors McPc 1748 and W 3469 than in TEPC 183, McPc 774, and Y 5781. 
The first two tumors had in addition relatively less cytoplasm and on the whole 
the appearance of these cells was more that of intermediate lymphocytes, 
whereas TEPC 183, McPc 774, and Y 5781 tumor cells had the appearance of
large "blast" cells with a relative increase of the proportion of cytoplasm over 
nucleus. 
Striking differences between the tumors were obvious with regard to the 
surface and intracytoplasmic immunoglobulins. Here again two groups of 
tumors were apparent: McPc 1748 and W 3469 showed abundant membrane- 
bound and scanty intracytoplasmic immunogloblins ( ee Fig. 1 a and b). It 
should be remembered that restaining of membrane immunoglobulins in the 
second step in this staining procedure may generate an increased intensity of 
the second staining not due to intracytoplasmic immunoglobulins. 
On the other hand the membrane immunofluorescence showed only a few 
spots on the cells of tumors TEPC 183 and McPc 774, and none at all on Y 
5781 cells; these last three tumors, by contrast, had abundant intracytoplasmic 
immunoglobulins, so that the pattern of intracytoplasmic staining was similar 
to that of plasmablasts or young plasma cells (Fig. 1 c e). 
Electron Microscopy (EM).--At least 400-500 cell profiles of each tumor 
were examined on three occasions with the microscopist unaware of the iden- 
tity of the individual tumors. The results for each tumor were identical on each 
occasion. 
Using cytoarchitectural features the tumors could be divided into two major 
groups (Fig. 2). The majority of cells in group I tumors (McPc 1748 and W 
3469) contained numerous cytoplasmic polysome clusters. There was little 
rough endoplasmic reticulum and the golgi zones were quite small. Many 
mitochondria were present. The nuclei had large areas of electron dense, clumped 
heterochromatin, a feature similar to that seen in the resting small lym- 
phocyte (Fig. 2 a and b). About 10% of cell profiles were lymphoblastoid or 
mitotic cells. 
Group II tumors, of which McPc 774 and TEPC 183 were typical, were com- 
prised predominantly of larger cells with much smaller nuclear to cytoplasmic 
ratios. Although many polysome aggregates were noted free in the cytoplasm, 
an extensively developed rough endoplasmic reticulum (RER) with various 
states of cisternal dilatation was prominent. The golgi was extremely well 
developed and again many mitochondria were present. Many of tbe cells 
showed prominent nucleoli and large areas of adielectronic euchromatin (Fig. 
3 a and b). 10-20% of the cell profiles had the electron microscopic features 
of small lymphocytes, lymphoblasts, mature plasma cells, and mitotic cells. 
Y 5781 contained cells with moderately developed RER and moderate 
numbers of cytoplasmic polysome aggregates. Y 5781 cells appeared to be 
 o
n
 August 22, 2007 
w
w
w
.jem.org
D
ow
nloaded from
 
Fie. 1. Mouse tumor cells, stained in suspension with a rhodamine-conjugated antimouse 
N-chain antiserum, flattened on slides, and stained after fixation with the same antiserum 
conjugated with fluorescein. (A) Phase contrast; (B) Specific visualization of rhodamine 
(surface immunoglobulins only); (C) Specific visualization of fluorescein (intracytoplasmic 
immunoglobulins plus some restaining of surface immunoglobulins). (a) Tumor McPc 1748: 
bright staining of surface immunoglobulins (B) and weak staining after fixation (C), mostly 
due to restaining of surface immunoglobulins; (b) Tumor W 3469: the cells show definite 
staining of surface immunoglobulins, a d some staining of the cytoplasm; (c) Tumor TEPC 
183: the surface immunoglobulins are very scanty, but still detectable as few spots, whereas 
intracytoplasmic immunoglobulins are clearly detectable; (d) Tumor McPc 774: surface 
immunoglobulins are barely detectable on a few ceils, that by contrast contain appreciable 
amounts of immunoglobulins i  the cytoplasm; (e) Tumor Y 5781: the cells appear devoid of 
surface immunoglobulins, a  detectable by immunofluorescent staining, and contain consider- 
able amounts of intracytoplasmic immunoglobulins. 
746 
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FIG. 2. (a) Cell from McPc 1748. Note the numerous cytoplasmic polysome clusters 
(arrows) and occasional strands of rough surfaced endoplasmic reticulum. X 10,000. (b) Cell 
from W 3469 showing similar EM features to McPc 1748. Note the prominent clusters of 
polysomes (arrows). X 10,000. 
747 
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FxG. 3. (a) Cell from TEPC 183. Typical plasmacytoid cell with extensively developed 
rough surfaced endoplasmic reticulum and numerous intercisternal A particles. )< 10,000. 
(b) Cell from McPc 774 with well developed rough surfaced endoplasmic reticulum and prom- 
inent intracisternai A type particles. )< 10,000. 
748 
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ANDERSSON ET AL. 749 
morphologically intermediate between the prototypes of groups I and II cells, 
although somewhat closer to those of group II (Fig. 4 a and b). 
An additional feature noted by EM was the variability of expression of the 
frequently described murine myeloma associated intracisternal A particles 
(19). In an extensive xamination of McPc 1748 and W 3469 cells no particles 
of this type were noted. In striking contrast, the majority of TEPC 183 and 
McPc 774 cell profiles contained large numbers of particles in their character- 
istic intracellular distribution (Fig. 5 a, b). These were often observed in meta- 
phase cells. 
Biochemical Studies: Synthesis of of IgM-- 
Polypeptide chains: Cell suspensions of the mouse tumors McPc 1748, 
W 3469, TEPC 183, McPc 774, and Y 5781 incorporated radioactive leucine 
linearly up to 6 h into total intracellular plus secreted protein and into immu- 
nologically precipitable IgM. Two distinct patterns of labeling of intracellular 
and secreted IgM were observed with the five tumor cell suspensions (Fig. 6). 
With three group II tumor cell suspensions--TEPC 183, McPc 774, and 
Y 5781--equilibration f the intracellular pool of IgM with newly synthesized 
radioactive IgM molecules was reached after 4 h. Consequently a steady state 
in the rate of secretion of radioactive IgM was reached at the same time (Fig. 
6 c-e). All three tumors produced labeled ~- and L-chains in the expected molar 
ratios as judged by polyacrylamide gel electrophoresis of the reduced and 
alkylated radioactive IgM. 
With the two group I tumor cell suspensions, McPc 1748 and W 3469, equil- 
ibration of the intracellular pool of IgM with radioactive molecules was not 
achieved within the 6-h labeling period (Fig. 6 a and b). Very little radioactive 
IgM was secreted. This is particularly evident from the amount of radioactive 
IgM secreted at 4 h of labeling by these two tumor cells, when compared to the 
three actively secreting tumor cells McPc 774, TEPC 183, and Y 5781 (Table 
II). The tumors produced ~- and L-chains in the expected molar ratios. Any 
possible production of excess L chain could again not be detected ue to the 
k-L-chain specificity of our anti-IgM antiserum (see above). 
Carbohydrate moieties: In close similarity to the results of the leucine-label- 
ing experiments, two distinct patterns of labeling of intracellular and secreted 
IgM were observed with incorporation of radioactive mannose into the five 
tumor cell suspensions (Fig. 7). 
With the three group II tumor cells equilibration of the intracellular pool of 
IgM with newly synthesized radioactive molecules was reached after 4-5 h. 
Consequently a steady state in the rate of secretion of IgM molecules was 
reached at the same time (Fig. 7 c-e). 
With the other two tumor cells, McPc 1748 and W 3469, no equilibration 
of the intracellular pool of IgM with radioactive IgM molecules was reached 
within the 6-h labeling period. Very little IgM was secreted (Fig. 6, a and b). 
The incorporated label was contained in the "core" sugars, glucosamines and 
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FIG. 4. (a) Low power micrograph of cells from Y 5781 showing moderately developed 
rough surface endoplasmic reticulum and occasional intracisternal A particles. X 5,250. (b) 
Cell from Y 5781. X 10,000. 
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FIG. 5. (a) McPc 774. )< 5,000 showing distribution of A particles in all cells of field. (b) 
TEPC 183. >( 14,000. Higher power view of particle distribution and morphology. 
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FIG. 6. Time-course of incorporation of [3H]leucine into intracellular (A) and extracellular 
(O) IgM of five IgM-producing tumor ceils. For details see the Materials and Methods. 
mannoses as analyzed after acid hydrolysis of the labeled, serologically pre- 
cipitated IgM as free-labeled sugars (see Materials and Methods). All five 
tumor IgMs carried similar amounts of labeled mannose, hence of "core" 
sugars. This could be judged from a comparison of the amount of leucine-label 
in the polypeptide portions with the amount of mannose-label in the carbo- 
hydrate portions of the five intracellular IgM molecules (Table III). Poly- 
acrylamide gel electrophoresis of the reduced and alkylated radioactive intra- 
cellular IgM showed that the tz chains but not the L chains carried the label, 
and thus the carbohydrate moieties. 
All five tumor cells, labeled for up to 6 h, contained very little galactose- or 
fucose-labeled IgM (Fig. 8). The data in Table II show that the amount of 
galactose and fucose radioactivity in 4-h-labeled intracellular IgM is very 
small and approximately the same for all five tumor IgMs. Also, in compari- 
son to leucine label, intracellular IgM from all five tumor cells carried very 
little galactose or fucose label (Table III). We conclude, that as in MOPC 
104E tumor cells (20) and mitogen-stimulated B cells (12), fucose and galac- 
tose residues are added just before, or at the time, IgM is secreted from the 
cells. 
The three group II tumor cells--TEPC 183, McPc 774, and Y 5781--secreted 
galactose- and fucose-labeled IgM from within the first 30 rain of labelings 
linearly up to 6 h. These tumor cells secrete large numbers of IgM molecules 
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TABLE II 
Rates of lgM Synthesis and Secretion and the Ratio of the Rates of Synthesis and Secretion of IgM 
Over Those of all Proteins in the Cell of Five Mouse Tumors as Compared to Small, Resting, 
Unstimulated B cells taken from (4) and 72-h Mitogen-Stimulated B Cells taken from 
(5) in Labeling Experiments with [SH]Leucine, 
[3H]Mannose, [3H)Galactose, [3H]Fueose 
Cells 
. _ IgM 
10 ~ X nH radioactivity 
(cpm/5 X 106 ceils incorporated 
in 4 h) 
Ratio of rates (IgM/total protein) 
Secreted Intracellular Secreted Intracellular 
[3H]Leucine-labeling 
Small, resting unstimulated 13 15 0.050 0.015 
B cells 
McPc 1748 19 65 0.058 0.020 
W 3469 35 130 0.090 0.040 
TEPC 183 330 210 0.33 0.060 
McPc 774 210 200 0.56 0.140 
Y 5781 125 120 0.41 0.160 
72-h mitogen-stimulated 300 130 0.35 0.090 
B cells 
[3H]Mannose-labeling 
Small, resting, unstimu- 2 20 0.020 0.025 
lated B cells 
McPc 1748 4 52 0.030 0.045 
W 3469 8 50 0.045 0.045 
TEPC 183 52 54 0.185 0.10 
McPc 774 100 160 0.455 0.225 
Y 5781 70 72 0.35 0.18 
72-h mitogen-stimulated 60 80 0.20 0.15 
B cells 
[3H]Galactose-labeling 
Small, resting, unstimu- ND ND - -  - -  
lated B cells 
McPc 1748 7 4 0.016 0.003 
W 3469 12 8 0.030 0.004 
TEPC 183 28 3 0.175 0.012 
McPc 774 92 8 0.260 0.006 
Y 5781 92 4 0.305 0.013 
72-h mitogen-stimulated 20 2 0.30 0.04 
B cells 
[SH]Fucose-labeling 
Small, resting, unstimu- ND ND - -  - -  
lated B cells 
McPc 1748 2 1 0.006 0.020 
W 3469 2 2 0.050 0.050 
TEPC 183 64 8 0.540 0.050 
McPc 774 13 1.7 0. 210 0.036 
Y 5781 28 1 0.140 0.050 
72-h mitogen-stimulated 20 2 0.30 0.040 
B cells 
* Data also shown in Figs. 6-8. 
ND, not detectable. 
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FIO. 7. Time-course of incorporation of [3H]mannose into intracellular (A) and extra- 
cellular (O) IgM of five IgM-producing tumor cells. For details see the Materials and Meth- 
ods. 
TABLE III 
Ratios of Radioaetivities Incorporated into Carbohydrate Moieties of IgM ([3H]Mannose-, 
[3H]Galactose-, [3H]Fucose-Labeling) over those Incorporated into 
Polypeptide Portions of I gM ([aH]Leucine-Labeling) * 
Tumor 
Mannose/leucine Galactose/leucine Fucose/leucine 
Secreted Intracellular Secreted Intracellular Secreted Intracellular 
McPc 1748 0.21 0.80 0.37 0.06 0.10 0.015 
W 3469 0.23 0.39 0.34 0.06 0.06 0.015 
TEPC 183 0.17 0.49 0.09 0.03 0.19 0.073 
McPc 774 0.71 0.80 0.65 0.04 0.09 0.009 
Y 5781 0.56 0.60 0.74 0.03 0.22 0.008 
* Data taken from Table II, Fig. 6 a-e, Fig. 7 a-e, and Fig. 8 a-e. 
which contain the "terminal" sugars. Polyacrylamide gel electrophoresis of the 
reduced and alkylated gatactose- and fucose-labeled IgM molecules secreted 
by the three tumor cells showed that the/z-chains, but not the L chains, carried 
the labels and therefore contained these "branch" sugars. 
The amount of galactose- and fucose-labeled IgM found in the secreted 
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FIG. 8. Time-course of incorporation of [3H]galactose (top) and [3H]fucose (bottom) into 
intracellular (A) and extracellular (O) IgM of five IgM-producing tumor cells. For details 
see the Materials and Methods. 
material of the McPc 1748 and W 3469 cells was very small. However, when 
the ratios of galactose to leucine and fucose to leucine incorporated into secreted 
lgM were examined, they did not differ significantly from those seen in the 
group II cells (Table III). The similarity in these ratios seen in the two groups 
suggests that the relatively low incorporation of branch sugars into released 
IgM is consistent with the small amount of IgM activity secreted during the 
period of observation. 
It was apparent that there was more radioactivity in galactose-labeled, 
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756 FIVE IgM-PRODUCING MOUSE TUMORS 
secreted McPc 774 and Y 5781 IgM than in TEPC 183 IgM (Table III). It 
was also evident that radioactive fucose labels TEPC 183 IgM more than 
McPc 774 and Y 5781 IgM (Table III). Analysis of the radioactivity contained 
in 5 h-fucose- or galactose-labeled secreted TEPC 183, McPc 774, and Y 5781 
IgM showed that galactose was mainly incorporated into galactose positions 
and fucose mainly into fucose positions of the carbohydrate moieties of IgM. 
Hence these differences may reflect quantitative differences in the amount of 
certain sugar residues in carbohydrate moieties of IgM. Heterogeneity in car- 
bohydrate moieties of glycoproteins i  a well-documented phenomemon (21). 
Ratios of rates of synthesis and secretion of IgM over the rates of synthesis and 
secretion of all cellular macromolecules: In Table II the ratios of rates of syn- 
thesis and secretion of IgM over those of all labeled cellular macromolecules 
are calculated from data obtained in a 4-h labeling period with radioactive 
leucine, mannose, galactose, and fucose. The five tumor cells are compared to 
unstimulated and to 72-h stimulated B cells (4, 5). It is evident hat in group I
tumor cells (McPc 1748, W 3469) IgM synthesis and secretion comprises a
much smaller part of the synthesis and secretion of all cellular macromolecules 
(between 2 and 4% of the intracellular and 6 and 9% of the secreted cpm in 
the four labeling experiments) than in group II tumor cells (between 6 and 
16% intracellular and 35 and 56% secreted). This was confirmed by the car- 
bohydrate incorporation studies. 
Turnover of newly synthesized IgM: Fig. 9 shows the disappearance of
labeled IgM from the five tumor cells when the five tumor cells were labeled 
for 4 h with radioactive leucine, then transferred into nonradioactive chase 
medium and the disappearance of labeled IgM from the cells and its appearance 
in the supernatant medium measured after various periods of chase time. 
In group I cells (McPc 1748 and W 3469) most IgM disappears with a rela- 
tively long median disappearance time (between 8 and 15 h). In group II cells 
two populations of IgM molecules are easily distinguishable. One disappears 
with a median time of 1.5-3 h. These rapidly disappearing IgM molecules 
represent between 65 and 75 % of all intracellular labeled IgM molecules in 
TEPC 183 and McPc 774 cells and 90% in Y 5781 cells. The remainder of the 
IgM molecules disappear slowly, in McPc 774 cells with a T1/2 between 8 and 
15 h. In TEPC 183 and Y 5781 cells the T1/2 of intracellular IgM in the second 
phase is 15-25 h. 
Stability of IgM synthesis n the presence of Actinomycin D: The five tumor 
cells were tested for the resistance of their IgM synthesis to inhibition of acti- 
nomycin D. Biosynthetic incorporation of radioactive leucine into IgM was 
measured in the presence and absence of 0.5 t~g/ml actinomycin D. The data 
in Fig. 10 are expressed as ratios of labeled amino acid incorporated into IgM 
to that incorporated into total cell protein during the same incubation period. 
The resistance of IgM synthesis to actinomycin D-inhibition relative to that 
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FIG. 9. Release of radioactive IgM from five tumor cells labeled for 4 h with [SH]leucine, 
thereafter placed in nonradioactive medium. Release (turnover) of labeled IgM was followed 
in aliquots of the labeled cells at different ime periods of chase as described in detail in the 
Materials and Methods. 
of all cellular proteins is slight in group I cells but marked in TEPC 183, Y 
5781, and McPc 774 cells. 
DISCUSSION 
Myeloma cells and their protein products have played an important role in 
the analysis of antibody synthesis and structure. It has been assumed that 
myeloma tumors represent clones of antibody-forming cells which have become 
malignant but retain their differentiated function. Hence, they can serve as 
useful models for the study of processes which take place in normal Ig-synthe- 
sizing cells. 
The IgM-producing BALB/c tumors described here could be separated into 
two groups using a number of morphologic and functional criteria. Group [ 
cells had strong surface immunofluorescence with anti-# antiserum, few cyto- 
plasmic membrane-bound polysomes, and synthesized only a small portion of 
their total cell protein as IgM. IgM synthesis was actinomycin D-sensitive. 
Its turnover was slow and intracellular equilibration of labeled precursors was 
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FIG. 10. The effect of actinomycin D (0.5 #g/ml) on the ratio of IgM synthesis in five 
tumor cells producing IgM. Ratios are given of the rates of IgM synthesis over the rates of 
synthesis of all cellular proteins at different time periods of incubation in the presence (O) 
or absence (O) of actinomycin D. Synthesis comprises IgM found inside the cells and secreted 
from the cells during the time period of incubation (2 h). Details are given in the Materials 
and Methods (see also ref. 4 and 5). 
difficult to attain. Although some 19S IgM was secreted, the amount was very 
small. Intracisternal A particles were not detectable in numerous electron 
microscopic sections of these cells. 
Group II cells had little surface Ig but intense intracellular fluorescence 
when cytoplasmic staining was performed with the same anti-/~ antiserum. 
Electron microscopy demonstrated an extensively developed RER and promi- 
nent Golgi zones. The synthetic ratio of IgM to total protein was high, and 
IgM turnover was rapid. IgM secretion was copious and its synthesis appeared 
to be relatively resistant to actinomycin D. The cells obtained from these 
tumors contained substantial numbers of intracisternal A particles. 
Abundant intracytoplasmic Ig and the lack of surface-bound Ig is strictly 
correlated with the development of the RER in group II cells. Although the 
development of the amount of rough endoplasmic reticulum in maturing B 
lymphocytes may be continuous the initiation of the development of it may 
be a discernible event during B cells maturation. In fact, stimulation of normal 
B lymphocytes by mitogens in the absence of DNA synthesis leads to the 
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ANDERSSON ET AL. 759 
development of immature plasmablasts with numerous intracytoplasmic poly- 
ribosomes, but no visible RER (22). These cells resemble the group I tumor 
cells. Upon release of the DNA synthesis inhibition, cells develop, which re- 
semble group I I  tumor cells. I t  appears likely that the analysis of more IgM- 
producing tumor cells will more clearly distinguish two groups (I and I I ) ,  
which are discontinuous with each other. 
The clear distinction between these two groups of IgM-synthesizing tumor 
cells prompted a comparison of their morphologic and functional features with 
those of lipopolysaccharide (LPS)-stimulated B cells (5, 6). Extensive studies 
had indicated that when normal murine B cells were exposed to this B-cell 
mitogen, they increased their cytoplasmic volume, developed an extensive 
RER with its associated polyribosomes and became more plasmacytoid (1, 2). 
Analysis of protein synthesis in these cells has demonstrated that the amount 
of Ig synthesis (as IgM) relative to total cell protein synthesis increased mark- 
edly. The turnover of the cell-associated IgM became more rapid as the major 
portion of the newly synthesized molecules was secreted without delay. Acti- 
nomycin D appeared to have little effect on IgM synthesis later in the re- 
sponse (5). 
Fig. 11 demonstrates the relationship between each of the tumors and LPS- 
stimulated B cells. The data obtained from the amino acid and carbohydrate 
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FIG. 11. Relative maturity of five IgM-producing tumor cells in comparison to normal 
mitogen-stimulated B cells. Ratios of rates of intracellular synthesis and of secretion of IgM 
over those of total protein synthesis and secretion at various times after mitogenic stimulation 
of normal B cells (5) are given by dashed lines. Data obtained with the five tumor cells (McPc 
1748,W 3469, TEPC 183, Y 5781, and McPc 774) (Table II) are indicated by arrows. 
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760 FIVE IgM-PRODUCING MOUSE TUMORS 
labeling experiments with each tumor have been superimposed on curves 
derived from identical experiments performed with stimulated B cells (5). 
McPc 1748 is analogous to a 10-20 h LPS-stimulated spleen cell suspension 
while McPc 774 closely resembles a 100-120 h stimulated cell suspension. None 
of the tumors tudied in this group appear to represent an unstimulated B cell. 
Group I tumor cells, like early B cells, had most of their cell-associated 
IgM at the surface. Initially they released IgM at a slower rate than group II 
cells which secrete their immunoglobulin with kinetics similar to mature 
plasma cells. After 6 h, the rates became similar as the pace of release was 
slowed in the late B-cell tumors. This biphasic release of cell-associated IgM 
could be explained either by the presence of two distinct populations of IgM 
molecules, maybe in two different populations of cells, or by the equilibration 
of labeled and unlabeled subunits in the face of a random assembly and secre- 
tion process, in which the 8S subunits are not assembled into polymers in the 
order in which they are synthesized. 
The possibility that two separate populations of IgM molecules could result 
from a separate regulation of the biosynthesis of membrane-bound and of 
secreted Ig is also supported by the differences observed in synthesis and turn- 
over of IgM in resting and in mitogen-activated B lymphocytes (4, 5), by the 
difference in size and carbohydrate composition of these different ypes of IgM 
(4, 5), and by studies with another mouse myeloma cell producing membrane- 
bound and secreted IgG (23). The problem of the intracellular segregation of 
Ig chains and their direction to either a surface or a secretory pool may be 
approached using the tumor cells as models. 
Comparison of the kinetics of incorporation of various labeled sugars into 
the IgM of the group I and II tumor cells indicated that molecules bearing 
the terminal sugars may have been associated with the cells for a longer period 
of time in group I cells. Although the carbohydrate composition of the cell- 
associated IgM was not chemically determined, the sugar to leucine ratio of 
the IgM secreted by each of the tumors revealed no systematic differences 
between group I and group II cells In both groups the sugar residues were 
associated exclusively with the /~-chains, however the labeling pattern sug- 
gested that there may be variations in the carbohydrate composition within 
groups I and II. 
The apparent dichotomy of effect of actinomycin D in the two groups of 
tumors was quite striking. The lack of sensitivity in group II argues for a 
longer period of utilization of preformed mRNA by these cells. Recent studies 
in Hela and L cells have indicated that this is probably not a function of mes- 
senger degradation but may represent a failure of re-initiation along the same 
mRNA molecules. This may be a function of the number or nature of the cyto- 
plasmic ribosomes or some other, as yet undetermined, factor (24, 25). 
It is difficult to interpret he biologic behavior of the tumors with respect 
to the relative maturity of the cells as a B lymphocyte. Animals bearing group 
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ANDERSSON ET AL. 761 
I tumors have enormously enlarged infiltrated spleens. When these spleens are 
passed into new animals 100 % of the recipients develop tumors. Spleens from 
group II-bearing animals produce tumors in a minority of recipients. This may 
reflect some variation in the surface or migratory properties of B cells at dif- 
ferent stages of maturation. 
The final striking disparity between group I and group II cells was in the 
presence of intracisternal A particles. We have been unable to detect these 
particles in many examinations of group I cells, while they are abundant in 
in group II cells. The particles do not bear a direct relationship to the prolifera- 
tive capacity of the cells, since both tumor types were fatal. Previous workers 
have attempted to correlate the presence of the particles with Ig production 
(26); however, EM studies of non-Ig-producing lines cloned from the MPC 11 
tumor revealed large numbers of particles (27). The ability to synthesize Ig is 
not an absolute requirement for their expression. This difference between 
group I and II cells may not be qualitative, but even if it represents a quan- 
titative difference, there may be some process involved in B-cell maturation 
which allows the flagrant expression of these presumably viral elements only 
by the more mature numbers of the series. In conclusion, it appears that these 
IgM-producing BALB/c tumors represent various stages of B-cell maturation 
which have been retained espite the malignant state. They should serve as a 
useful model for examining the process of B-cell maturation which results in 
the IgM antibody-secreting cell. 
SUMMARY 
Five adjuvant induced BALB/c tumors producing IgM--McPc 1748, 
W 3459, TEPC 183, McPc 774, and Y 5781--were characterized morpho- 
logically by electron microscopy, analysis of the distribution of surface-bound 
and intracytoplasmic IgM using immunofluorescence, and by biochemical 
study of IgM synthesis, turnover, and secretion. The cells of different tumors 
appear to represent different stages in B-cell maturation when'compared to 
normal, lipopolysaccharide-stimulated B cells. Thus, McPc 1748 tumor cells 
resemble 10-25-h stimulated normal B cells, 3469 cells resemble 20-35-h stim- 
ulated B cells, TEPC 183 cells resemble 45-55-h stimulated B cells, Y 5781 
cells resemble 80-110-h stimulated B cells, and McPc 774 cells resemble 100- 
130-h stimulated B cells. 
The able technical assistance of Misses M. Gidlund, Dorothee Jablonski, Ingrld M611eg~,rd 
Rosmary Chou, and Susan Dittmar is gratefully acknowledged. 
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